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LETTER
Concomitant fragile
X-associated tremor ataxia
syndrome and Parkinson’s
disease: a clinicopathological
report of two cases
INTRODUCTION
Parkinsonism is common in fragile
X-associated tremor/ataxia syndrome
(FXTAS) but its underlying pathophysiology
remains unknown. Our group reported a
patient with FXTAS and parkinsonism, and
in vivo evidence of presynaptic and postsy-
naptic nigrostriatal dysfunction.1 We report
the histological ﬁndings of this case (case 1)
and another case with dual pathologies of
FXTAS and Lewy body Parkinson’s disease
(PD).
METHODS
Genetic testing for FXTAS was requested in
seven cases from the Queen Square Brain
Bank for Neurological Disorders (QSBB)
based on the characteristic radiological
‘middle cerebellar peduncle’ (MCP) sign
(case 1, diagnosis conﬁrmed in life) and
histological ﬁndings of round, eosinophilic
p62-positive neuronal intranuclear inclu-
sions in the hippocampus or unexplained
cerebellar degeneration (6 postmortem
cases were tested). Two cases were positive
for FMR1 premutation and both showed
histological features of FXTAS and PD. The
QSBB brain donor programme was
approved by a Research Ethics Committee
and written consent for research was
obtained from all cases.
CASE REPORTS
Case 1
A 68-year-old man presented with a
10-year history of slowly progressive
right-hand tremor. There was no family
history of neurological disorders or mental
retardation. Examination showed hypomi-
mia, asymmetric rest and kinetic tremor,
rigidity, mild bradykinesia and inability to
tandem walk. The patient was diagnosed
with tremor-predominant PD but did not
respond to L-dopa (600 mg/day). Over the
next few years he developed mild cognitive
impairment, gait ataxia and intention
tremor. Brain MRI demonstrated the MCP
sign and diffuse atrophy. Genetic analysis
conﬁrmed FMR1 premutation with 87 CGG
expansion. 123I-FP-CIT SPECT revealed
asymmetric reduced tracer uptake with the
right side more affected. D2 receptor
(123I) IBZM-SPECT (IBZM) scan showed
slightly reduced tracer uptake bilaterally.
There was clinical and neurophysiological
evidence of large ﬁbre axonal peripheral
neuropathy. The patient’s University of
Pennsylvania Smell Identiﬁcation Test
(UPSIT) score was 25/40 (severe hypos-
mia: 19–25). His condition gradually
deteriorated and he died of pneumonia at
age 72.
Case 2
A 21-year-old man was diagnosed with
schizophrenia and his symptoms responded
well to long-term ﬂuphenazine. At the age
of 35, he developed a right-hand tremor
initially attributed to the neuroleptic treat-
ment. The tremor persisted despite switch-
ing ﬂuphenazine to olanzapine 5 mg/day
and administering anticholinergics (orphe-
nadrine and procyclidine). His tremor
remained stable and only began to deterior-
ate at age 51 along with the onset of slurred
speech and dragging of right leg.
Examination showed mild hypomimia,
hypophonia, restricted downgaze, slow ver-
tical saccades, jaw and tongue tremor, inter-
mittent right-sided predominant hand
tremor, bradykinesia and cogwheel rigidity.
Olanzapine was replaced by quetiapine
200 mg/day and L-dopa (300 mg/day) was
administered without any improvement.
Brain MRI showed global atrophy without
the MCP sign. At age 58, his symptoms
rapidly deteriorated with severe hand
tremor and frequent falls requiring a wheel-
chair. 123I-FP-CIT SPECT demonstrated
asymmetrical reduction of tracer uptake in
putamen and left caudate. A clinical diagno-
sis of progressive supranuclear palsy (PSP)
was made due to the rapid motor deterior-
ation, postural instability, restriction of
downgaze and absence of L-dopa response.
He died of pulmonary embolism at age 59.
Neuropathological ﬁndings prompted
genetic testing and the identiﬁcation of
FMR1 gene premutation with 100 CGG
expansions.
NEUROPATHOLOGICAL EXAMINATION
In both cases, histological examination
demonstrated widespread p62-positive
and ubiquitin-positive and 1C2-negative
neuronal and glial intranuclear inclusions
with mild Purkinje cell depletion consist-
ent with FXTAS. There was loss of pig-
mented neurons in the substantia nigra
with α-synuclein-positive Lewy bodies, in
keeping with PD. Lewy body pathology
conformed to Braak stage 5 in case 1 and
stage 3 in case 2. Age-related neuroﬁbril-
lary tangle pathology was also noted in
both cases (Braak and Braak stage II in
case 1 and stage I in case 2). An acute left
middle cerebral artery territory infarction
was observed in case 2.
DISCUSSION
In the literature, only 13 of 29 (45%)
cases with FMR1 premutation and parkin-
sonism had abnormal dopamine trans-
porter scans (see online supplementary
table) and it is likely that these 13 cases
may have had concomitant PD pathology
akin to the two cases in this series. On the
other hand, IBZM scans were only avail-
able in four cases with FMR1 premutation
including our case and all had abnormal
ﬁndings (see online supplementary table).
We propose that postsynaptic dopamin-
ergic striatal pathway dysfunction is
responsible for parkinsonism in indivi-
duals with FXTAS. FMR1 premutation
carriers with an abnormal dopamine
transporter scan probably signiﬁes the
presence of concomitant PD pathology
and may have a rapidly progressive
disease course due to the dual patholo-
gies. These patients may beneﬁt from L-
dopa therapy.
Of the 22 FXTAS cases with post-
mortem data (table 1), concomitant
pathologies were identiﬁed in nine cases
(41%): four had Alzheimer’s disease
pathology,2 one had multiple sclerosis
(MS)2 and four had PD pathology includ-
ing the two cases presented here.2 3
It is difﬁcult to ascertain the exact contri-
bution of each pathology to the clinical
course of parkinsonism in our cases. In case
2, the long-term use of neuroleptics compli-
cated the clinical picture, thus the long-
standing hand tremor could have been
caused by a combination of FTXAS and
neuroleptics. However, at age 51, the
deterioration of hand tremor, relentless
progression of parkinsonism and the onset
of typical features of PD including jaw and
tongue tremor collectively marked the
onset of an additional underlying neurode-
generative process of PD. Both cases had a
relatively benign course in the ﬁrst decade
of symptom onset followed by rapidly pro-
gressive parkinsonism and motor disability
leading to death. This rapid deterioration is
atypical for either FXTAS or PD. Indeed,
the clinical diagnosis for case 2 was revised
to PSP. Among the four patients with dual
FXTAS and PD pathology in the litera-
ture,2 3 the time from onset to use of
walking aid (median: 7.5 years) and life
expectancy (median: 11 years) are much
shorter than in other patients with isolated
FXTAS, in whom the median time to
walking aid is 15 years and median survival
is 21 years.4 These data suggest that the
synergistic effect of more than one neuro-
degenerative condition might have
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contributed to an accelerated disease
course. Carriers of FMR1 premutation with
concomitant Alzheimer’s disease,2 hetero-
zygous Parkin mutation5 or MS2 have been
reported and these secondary pathological
processes have been postulated to modulate
the effect of FMR1 premutation.
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Table 1 Features of 22 reported postmortem FXTAS cases
Duration from
onset (years)
CCG
repeats MCP sign
Additional
neuropathological
findingsWheelchair Death
Greco et al3; 11 males6 6 10 113 – –
– 13 80 – –
NA 5 80 Y –
13 14 71 – PD
12 19 105 – –
7 13 77 Y –
5 6 88 Y –
NA 3 92 – –
13 16 88 Y –
4 6 93 Y –
NA 1 65 – –
Tassone et al2; 8 females NA NA 70 – –
– 10 80 N AD (B&B V-VI)
– 6 87 – –
– 14 75 Y MS
– 7 65 – AD (B&B V-VI)
4 7 – N AD (B&B V-VI)
4 6 59 N PD
– 8 78 – AD (B&B V-VI)
Louis et al; 1 male7 7 9 90 – –
Present series: De Pablo-Fernandez
et al; 2 males
13 14 72 Y PD (Braak 5)
7 8 100 N PD (Braak 3)
Total: 8 females; 14 males 8 9 Y
64% (7/11)
AD, Alzheimer disease; B&B, Braak and Braak stage for Alzheimer; Braak, Braak stage for Parkinson’s disease; FXTAS,
fragile X-associated tremor/ataxia syndrome; MCP, middle cerebellar peduncle; MS, multiple sclerosis; N, no; NA, not
applicable; PD, Parkinson’s disease; Y, yes.
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